SUPPLEMENTARY RESULTS

Supplementary
Supplementary T ab le 3 . Retinoid ligand docking into the RP E 6 5 active site. M B -0 0 1 ( orange) , palmitate ( cyan) and iron ( b rown sphere) are shown in the panels on the right to provide a frame of reference. Supplementary Figure 1 . Preparation of RPE65 and MB-001 for crystallization studies. MB-001 was synthesized as described in the online methods. RPE65 purification was performed essentially as described previously except that C 8 E 6 was used in place of C 8 E 4 as the detergent 1 . MB-001 was added to the RPE65-containing samples at the detergent extraction step of purification as well as to the final purified sample just prior to initation of the crystallization trials. The same procedure was used for the emixustat-RPE65 crystallization experiments. The scale bar in the image of the crystals obtained from the procedure indicates a horizontal length of 150 m. . C onformational differences b etw een residues of th e memb rane-entry port in close prox imity to th e aliph atic rings of th e inh ib itors. F or ( a) , emix ustat-b ound structure, and ( b ) , M B -0 0 1 -b ound structure, the inhib itor-b ound structure is shown in light orange, the originally determined delipidated RP E 6 5 structure ( P D B accession code 3 F S N ) in grey and the lipid-emb edded " active" structure ( P D B accession code 4 F 2 Z ) in light green. I n b oth inhib itor structures, residues that make up the memb rane entry port including P he1 96 , P he2 6 4 and T rp 2 6 8 adopt conformations similar to those ob served for the lipid-emb edded " active" RP E 6 5 structure. 
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